Royce & Associates LP Enovis Corp Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Enovis Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,418,923 shares of ENOV stock, worth $80.6 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
2,418,923
Previous 2,490,806
2.89%
Holding current value
$80.6 Million
Previous $95.2 Million
20.3%
% of portfolio
0.82%
Previous 1.09%
Shares
14 transactions
Others Institutions Holding ENOV
# of Institutions
316Shares Held
64.8MCall Options Held
1.64MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA6.4MShares$213 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$181 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO4.74MShares$158 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.92MShares$97.3 Million0.02% of portfolio
-
Davenport & CO LLC2.84MShares$94.7 Million0.52% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $1.8B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...